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Abstract
Background—Introduction of the yellow obese gene (Ay) into mice (KKAy) results in obesity
and diabetes by 5 weeks of age.
Methods—Using this model of type 2 diabetes, we evaluated male and female 6–8 month old
wild type (WT, n=10) and KKAy (n=22) mice subjected to myocardial infraction (MI) and
sacrificed at day (d) 7.
Results—Despite similar infarct sizes (50±4% for WT and 49±2% for KKAy, p=N.S.), the 7 d
post-MI survival was 70% (n=7/10) in WT mice and 45% (n=10/22) in KKAy mice (p<0.05).
Plasma glucose levels were 1.4 fold increased in KKAy mice at baseline, compared to WT
(p<0.05). Glucose levels did not change in WT mice but decreased 38% in KKAy post-MI
(p<0.05). End-diastolic and end-systolic dimensions post-MI were smaller and fractional
shortening improved in the KKAy (5±1% in WT and 10±2% in KKAy, p<0.05 for all). The
improved cardiac function in KKAy was accompanied by reduced macrophage numbers and
collagen I and III levels (both p<0.05). Griffonia (Bandeiraea) simplicifolia lectin-I staining for
vessel density demonstrated fewer vessels in KKAy infarcts (5.9±0.5%) compared to WT infarcts
(7.3±0.1%, p<0.05).
Conclusion—In conclusion, our study in KKAy mice revealed a paradoxical reduced post-MI
survival but improved cardiac function through reduced inflammation, extracellular matrix
accumulation, and neovascularization in the infarct region. These results indicate a dual role effect
of obesity in the post-MI response.
Address for Correspondence and address below where research was conducted: Ganesh V. Halade Ph.D., Division of Cardiovascular
Disease, Department of Medicine, The University of Alabama at Birmingham, ZRB 310A, 1720 2nd Ave South, Birmingham,
Alabama 35294, Phone: 205-996-4139 (office), halade@uab.edu.
All authors take responsibility for all aspects of the data and discussion presented.
Conflict of interest: None.
NIH Public Access
Author Manuscript
Cardiovasc Pathol. Author manuscript; available in PMC 2014 November 01.
Published in final edited form as:
Cardiovasc Pathol. 2013 ; 22(6): 481–487. doi:10.1016/j.carpath.2013.06.002.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Keywords
obesity; diabetes; extracellular matrix; heart failure; inflammation; myocardial infarction
Introduction
The prevalence of obesity has increased substantially over the past 30 years, and the current
obesity estimate indicates that over 35% of the population in developed countries is either
obese or overweight [1]. Obesity, defined as a body mass index (BMI) of 30 or greater,
induces a state of chronic low-grade inflammation, and adipose tissue derived inflammation
has been shown to be a key component of insulin resistance and type 2 diabetes [2]. In
humans, obesity is linked with hypertension and an increased risk of cardiovascular disease
that decreases life expectancy [3, 4]. While obesity and diabetes are well-known risk factors
for heart failure after myocardial infarction (MI), heart failure patients with BMIs >30
actually show improved survival compared to patients with BMI <25 [5, 6]. The
mechanisms that explain this obesity paradox remain to be elucidated.
The KKAy mouse strain was developed by introducing the Ay/a mutation onto the inbred KK
strain of native Japanese mice [7]. By five weeks of age, KKAy mice are hyperglycemic and
hyperinsulinemic, with increased degranulation of β cells and hypertrophy of pancreatic islet
cells that reflect increased production of insulin [8]. By 16 weeks of age, both sexes of
KKAy mice show blood glucose levels approaching 400 mg/dl, indicative of marked
hyperglycemia [8]. This model, therefore, closely mimics the obesity and type 2 diabetes
phenotype seen in humans. The objective of the present study was to use this unique mouse
model to determine the impact of obesity and hyperglycemia on MI. We focused on
functional, morphological, and histological features of the post-MI left ventricle (LV).
Methods
All animal procedures were conducted according to the “Guide for the Care and Use of
Laboratory Animals” (Eight Edition, 2011) and were approved by the Institutional Animal
Care and Use Committee at the University of Texas Health Science Center at San Antonio.
Mice
The mice used in this study were 6 to 8 month old male and female mice (n= 17 wild type
(WT), 9 male and 8 female, and n=32 KKAy, 20 male and 12 female. Of these, 7 WT and 10
KKAy mice were used for day (d) 0 controls. A total of 10 WT and 22 KKAy mice were
enrolled into the 7d MI study. MI was induced by surgical ligation of the left anterior
descending coronary artery, as described previously [9]. Buprenorphine (0.1 mg/kg, I.P.)
was given immediately after the chest was closed. Survival was monitored daily, and all
surviving mice underwent echocardiographic assessments during the terminal procedure.
Non-surviving mice underwent autopsy evaluation to determine to cause of death.
Blood glucose measurements
Postprandial blood samples were collected during sacrifice to determine glucose levels.
Glucose levels were measured using a glucose monitor according to manufacturer
recommendations (Ascencia Elite™; Bayer, Mishawaka, IN, USA).
Transthoracic echocardiography
For the echocardiography analysis, 0.5–2% isoflurane in a 100% oxygen mix was used to
anesthetize the mice. The electrocardiogram and heart rate were monitored continuously
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during the imaging procedure. Images were acquired using the Vevo 770 high-resolution in
vivo imaging system (Visual Sonics) and were taken at heart rates >400 beats/min to obtain
measurements that were physiologically relevant. Measurements were taken from two-
dimensional parasternal short axis (m-mode) recordings acquired mid-papillary.
Echocardiographic studies were performed prior to sacrifice for both d0 controls and 7d
post-MI mice. For each parameter, three images from consecutive cardiac cycles were
measured and averaged.
Post-necropsy LV processing and infarct size analyses
At 7d post-MI, the mice were anesthetized under 1–2% isoflurane, and the mice were
injected with heparin (4 units per g body weight; ip). After 5 minutes, the carotid artery was
cut, and blood was collected and centrifuged for plasma collection. The coronary
vasculature was flushed with cardioplegic solution to arrest the heart in diastole [10]. The
heart and lung were removed, and the left and right ventricles were separated and weighed
individually. The LV was further divided into base, mid-cavity, and apexs ections, and all
three LV sections and right ventricle were stained with 1% 2,3,5 triphenyltetrazolium
chloride (TTC; Sigma Inc.) and photographed for infarct size determination. The % infarct
size was calculated by the length of the infarct and non-infarct segments. In brief, infarct
size was calculated from the TTC stained image by tracing the infarcted perimeter and the
non-infarcted perimeter of the LV. The measurements were combined to calculate the total
LV infarct size by using this formula.
. The mid cavity
section was fixed in 10% zinc-formalin and paraffin-embedded for histological examination.
The lungs and tibias were removed, and the lung wet weights and tibia lengths were
measured.
Plasma proteomic profiling
Plasma samples (100 μl) were analyzed by the RodentMAP® version 2.0 Antigens (Myriad
Genetics Inc.), and concentrations of 58 analytes were measured by a Clinical Laboratory
Improvement Amendments (CLIA) certified biomarker testing laboratory using
reproducible, quantitative, multiplexed immunoassays [11]. Plasma analytes with values
below the limit of detection were excluded from the analysis.
Histology and immunohistochemistry
Mid cavity transverse sections of the LV were embedded in paraffin, sectioned at 5 μm, and
stained using hematoxylin and eosin. Immunohistochemistry was performed with the use of
the Vectastain ABC kit (Vector Labs). HistoMark Black (KPL Inc.) was used to visualize
positive staining, with eosin as a counterstain. Negative controls included no primary and
IgG-matched isotype antibodies. The following primary antibodies were used: macrophages
(Mac 3, Cedarlane CL8943AP, 1:100 dilution); collagen I (Sigma, clone Col-1, C 2456,
1:2000 dilution); and collagen III (Cosmo Bio Co. Ltd, LSL-LB-1393, 1:200 dilution).
Griffonia (Bandeiraea) Simplicifolia Lectin I (GSL I, Vector Labs, B-1105, 1:50 dilution)
binds specifically to galactosyl residues and was used to label the vascular endothelium [12].
Staining areas were quantified using Image-Pro software (Media Cybernetics) to calculate
percentage of total area stained positive [13].
Statistical methods
Data are presented as mean±SEM. Multiple group comparisons were performed using the
one-way ANOVA, followed by the Student Newman-Keuls post test. Two group analyses of
WT and KKAy were compared using unpaired t-test. Statistical analyses were performed
using Graph Pad Prism. A value of p<0.05 was considered statistically significant.
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Results
KKAy mice showed reduced survival post-MI
At 7d post-MI, the survival rates were 70% for WT (7/10) and 45% for KKAy (10/22;
p<0.05). The increase in mortality in the KKAy was equally attributed to perioperative and
postoperative mortality. Of the postoperative deaths in KKAy groups, 3 of the 5 (60%) were
due to cardiac rupture. The 1 postoperative death in the WT group was due to cardiac
rupture (Table 1; p=n.s.).
Body weights and glucose concentrations were higher in the KKAy mice at baseline and
decreased to normal levels post-MI
The KKAy mice developed obesity (Figure 1a) and overt diabetes (Figure 1b). In response to
MI, the body weights significantly decreased in the KKAy mice, while body weights did not
change in the WT mice post-MI (Figure 1b). Hypoglycemia and hyperglycemia both
increase the risk of heart failure after acute MI [14]. In the d0 control KKAy mice, blood
glucose levels were 1.4 fold higher than WT d0 control levels, indicating pronounced overt
diabetes (Figure 1b). In response to MI, blood glucose levels plummeted in the KKAy mice,
while levels remained similar between the control and MI groups for the WT (Figure 1b).
Improved cardiac function in KKAy mice post-MI
Echocardiographic, necropsy, and infarct size analyses for WT and KKAy mice at 7d post-
MI are shown in Table 2. The echocardiographic and morphometric analyses were analyzed
separately by sex, and no differences seen for the WT male vs. female or KKAy male vs.
female comparisons. For example, end systolic dimensions between male and female WT
post-MI groups had a p=0.55, and the male and female KKAy post-MI groups had a p=0.89.
For this reason, both sexes were combined for further analyses. At d0, the controls
demonstrated no differences in LV mass, RV mass, and lung wet weights. Post-MI, both
groups showed similar infarct sizes (50±4% for WT and 49±2% for KKAy, p=0.79) and
significant increases in LV mass compared with their respective d0 controls (p<0.05 for
both).
In response to MI, WT and KKAy mice demonstrated significant increases in LV end-
diastolic dimensions and end-systolic dimensions, and decreases in posterior wall thickness
and fractional shortening compared with their respective d0 controls (p<0.05 for all).
Despite the fact that the KKAy mice were obese and diabetic, the decreases in post-MI end-
diastolic and end-systolic dimensions were attenuated compared to the WT mice at 7d post-
MI. Due to the improved dimensions, fractional shortening was improved in the KKAy mice
post-MI (p<0.05). The RV mass, LV mass, and lung wet weight all increased in the WT and
KKAy post-MI groups, compared to the respective d0 controls (p<0.05 for all). The increases
in RV and lung wet weights indicate pulmonary edema, consistent with post-MI cardiac
remodeling.
Post-MI macrophage numbers were decreased in KKAy mice at d7 post-MI
To investigate potential mechanisms and to explain the improved cardiac function in the
surviving KKAy mice post-MI, LV sections were stained for macrophages. Macrophages
migrate to the site of injury post-MI to clear necrotic myocyte and apoptotic neutrophil
debris [15, 16]. As such, macrophages coordinate the balance between pro- and anti-
inflammatory actions to resolve inflammation [16]. At 7d post-MI, the KKAy mice exhibited
fewer macrophages in the infarct region compared to WT post-MI mice (p<0.05, Figure 2).
The reduced macrophage density suggests either debris was cleared earlier or that fewer
macrophages infiltrated into the infarct area to resolve inflammation.
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CD40, CD40 ligand, and macrophage-derived chemokine are differentially expressed post-
MI in the KKAy mice
The plasma proteomic profiling data set is provided in the supplemental table 1. Of 58
plasma analytes evaluated, CD40, endothelin, lymphotactin, macrophage derived
chemokine, myoglobin, serum glutamate oxaloacetic transaminase, RANTES (CCL5), tissue
factor, and von Willebrand factor were different (all p<0.05). All were reduced in the KKAy
plasma, with the exception of macrophage derived chemokine and RANTES (CCL5) that
increased. CD40 and CD40 ligand, eotaxin, epidermal growth factor, macrophage derived
chemokine, myoglobin, oncostatin, serum glutamate oxaloacetic transaminase, and von
Willebrand factor were different between WT and KKAy at day 7 post-MI (all p<0.05). Of
these, three analytes showed interesting patterns that varied by genotype: a) CD40 was
lower in the KKAy mice at baseline and stayed low post-MI, while WT levels increased
post-MI; b) CD40 ligand levels were similar at baseline, but post-MI WT levels increased
while KKAy levels remained the same; and c) macrophage derived chemokine levels
increased at baseline in the KKAy mice and increased post-MI in WT but not KKAy. CD40 is
a pro-inflammatory stimulus that binds to the CD40 ligand expressed by macrophages,
fibroblasts, endothelial cells, and smooth muscle cells [17]. Post-MI, the KKAy mice showed
decreased CD40, CD40L, and MDC levels compared to WT, consistent with the reduced
macrophages density measured by immunohistochemistry.
Reduced collagen I and III levels in KKAy mice post-MI
The interstitial spaces of the myocardium contain collagen type I and III fibers. Collagen I is
about 85% and III is about 11% of the normal cardiac extracellular matrix [18]. Myocardial
extracellular matrix deposition is an indispensable part of post-MI wound healing that also
contributes to ventricular stiffness and dysfunction [18]. In the WT mice, there was
increased expression of collagen I and III compared to KKAy mice at 7d post-MI (Figure 3a–
d). The reduced deposition of collagen I and III would likely reduce stiffness in KKAy mice,
which could explain the improved cardiac function post-MI.
Reduced neovascularization in the healing heart of KKAy mice
Neovascularization is an essential component of cardiac remodeling after MI, in order to
establish new blood supply network for the infarcted region [19, 20]. Therefore, we
measured vessel density in the healing myocardium of WT and KKAy mice at 7d after MI.
Immunohistochemical studies using GSL-1 revealed fewer vessels in infarct area of KKAy
mice compared to WT (Figure 4a and b), indicating increased granulation process following
MI. Plasma vascular endothelial growth factor (VEGF)-A protein levels remain unchanged
in the KKAy mice compared to WT at 7d post-MI. This evidence of reduced
neovascularization in KKAy mice indicates that additional studies on other angiogenic
factors and infarct area granulating factors in diabetes and obesity setting are warranted.
Discussion
Obesity and diabetes mellitus are common comorbidities in acute MI and heart failure
patients [21, 22]. We used the KKAy mice to evaluate post-MI remodeling in a model of
obesity and type 2 diabetes. KKAy mice develop spontaneous diabetes at an early age and
polyuria that increases urine excretion volume from 1.5±0.3ml at 5 week to 9.5±1.2ml by 12
weeks of age [7, 8, 23]. The major findings of this study were that the KKAy mice post-MI
showed: 1) increased mortality due to increase rupture rates, 2) attenuated inflammatory
response, as evidenced by altered CD40, CD40 ligand, and macrophage derived chemokine
levels and reduced macrophage infiltration into the infarcted area, 3) reduced collagen I and
III levels, and 4) reduced neovascularization in the infarcted area of KKAy mice. These
results indicate that diabetes worsen post-MI survival but attenuate LV remodeling in
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surviving mice by modulating inflammation, collagen synthesis, and neovascularization.
This study sheds light on mechanisms that help to explain the obesity paradox.
The decreased post-MI survival and increased rupture events in male KKAy mice are similar
to rates observed in other strains. Gao et al reported that male mice are prone to post-MI
mortality and rupture events [24]. Having increased testosterone levels in male mice
contributes to acute early remodeling and rupture that is not seen in female mice or estrogen-
treated castrated males [25]. Decreased post-MI survival and increased rupture events in the
KKAy male mice may associate with chronic inflammation in the diabetic setting [26].
Frangogiannis and colleagues demonstrated that in post-MI inflammation, macrophages are
capable of exerting stimulatory actions by secreting mediators that augment inflammation
and inhibitory pro-resolving effects through the removal of inflammatory neutrophils [16,
27]. KKAy mice had higher levels of plasma macrophage derived chemokine at baseline that
explains the non-significant increase in inflammatory response and attenuated LV
dysfunction in KKAy mice. Post-MI WT and KKAy showed increased levels of several
plasma analytes, including macrophage inflammatory protein 1 beta, macrophage
inflammatory protein 1 gamma, macrophage inflammatory protein 2, myeloperoxidase and
tissue inhibitor of matrix matelloproteinase compared to their respective controls.
Surprisingly, KKAy mice showed fewer macrophages in the infarcted area. Pre-existing
chronic inflammation in KKAy mice might sensitize signaling for inflammatory cell
recruitment that is required for neutrophil clearance and removal of necrotic myocytes in
post-MI remodeling event.
CD40 ligand is a transmembrane protein that belongs to the tumor necrosis factor
superfamily and interacts with the CD40 receptor. Longitudinal and cross-sectional studies
in humans shows that acute and chronic heart failure are characterized by evidently raised
levels of CD40 and CD40 ligand [28]. Lower levels of CD40 and CD40 ligand in KKAy
mice associates with lower ventricular dysfunction measured on 7d compared WT mice.
This is the first report that reduced CD40–CD40L interactions in KKAy mice may decrease
macrophage activation and attenuate ventricular dysfunction.
Post-MI myocardial repair is a dynamic process involving an inflammatory response that
clears the necrotic tissue, and replaces with collagen, ultimately leading to granulated and
healed scar. Macrophages comprise an important component of the inflammatory infiltrate.
Infiltrated macrophages are not only responsible for eliminating the neutrophils to limit the
expansion of the infarct, but also secrete growth factors, such as TGF-β1, which regulate the
activity of fibroblasts. Phenotypically modified fibroblasts, myofibroblasts, play a central
role in progression of fibrosis and their ability to produce procollagens [29]. Previous study
reports enhanced collagen synthesis in diabetic rodents and post-MI remodeling, [30] To our
surprise, having enhanced baseline inflammation due to obesity and diabetes in KKAy mice
enhanced the reparative phase leading to a more granulated scar and improved cardiac
function. Among many collagens type I and III are major collagens. Type I collagen links
mainly with thick fibers that confer tensile strength and resistance to stretch and
deformation. Collagen type III allies with thin fibers and provides resilience depending on
the cross-linking or alignment [18, 31]. Reduced collagen I and III deposition in KKAy mice
may contribute to reduced stiffness and improved LV function in post-MI setting. Given
reduced collagen I and III indicates early post-MI scar granulation in KKAy mice due to
enhanced non-collagen extracellular matrix deposition. Furthermore, post-MI KKAy mice
showed reduced vascularization and signs of earlier granulation tissue formation. Post-MI
neovascularization relies heavily on increased VEGF as an angiogenic stimulus [32]. In the
present investigation, post-MI changes in macrophages density and early scar granulation
compensated for the reduced neovascularization. In the present investigation, post-MI
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changes in macrophages density and early scar granulation compensate for reduced
neovascularization. Our overall results introduce new questions as to the contribution of
extracellular matrix proteins in the post-MI remodeling response in the setting of obesity.
Conclusion
We are the first to report dichotomous results in KKAy obese and diabetic mice in the post-
MI setting, which mirrors clinical observations of the obesity paradox. KKAy mice showed
increased post-MI mortality, while survivors had improved cardiac function accompanied by
reduced macrophages, collagen I and III, and neovascularization. Our results provides a
strong foundation for future studies to focus on proteins that stabilize the post-MI scar in the
early inflammatory setting, which could lead to improved outcomes in heart failure patients.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Summary
We observed dichotomous results in KKAy obese and diabetic mice in the post-MI
setting, which mirrors clinical observations of the obesity paradox. KKAy mice showed
increased post-MI mortality, while survivors had improved cardiac function accompanied
by reduced macrophages, collagen I and III, and neovascularization. Our results provides
a strong foundation for future studies to focus on proteins that stabilize the post-MI scar
in the early inflammatory setting, which could lead to improved outcomes in heart failure
patients.
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Figure 1.
Body weight and glucose levels were increased in KKAy mice. (a) KKAy mice showed
higher body weights at baseline but, decreased post-MI compared d0 KKAy controls. (b)
Plasma glucose levels were higher in the KKAy mice at baseline, and decreased post-MI
compared to d0 KKAy controls. The post-MI percent change in body weight and glucose
levels are presented in (c) and (d), respectively. n=7–9/group, *p<0.05 vs. WT d0 control,
¥p<0.05 vs. KKAy d0 control, values are mean ± SEM.
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Figure 2.
Histological changes in LV of WT and KKAy mice post-MI. WT and KKAy mice showed
inflammation with extensive necrotic changes compared to d0 controls. Hematoxylin and
eosin stained LV images in WT (a, b) and KKAy (c, d) mice at d0 and post-MI d7. n=7–9/
group (magnification is 40x, scale bar is 100 μm).
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Figure 3.
Macrophages density was reduced in KKAy mice at d7 post-MI compared to WT. LV mid
cavity sections were immunostained for macrophages at d0 and post-MI d7 (a, b WT and c,
d KKAy). Post-MI KKAy mice showed reduced macrophages (circled brown stained cells) in
the infarct region compared to the WT infarct region (magnification is 40x, scale bar is 100
μm). (e) Quantification of percent stained area, n= 4–5/group, *p<0.05 vs. WT d7 post-MI,
Values are mean ± SEM.
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Figure 4.
The KKAy mice showed reduced collagen I and III accumulation in the infarct region at d7
post-MI. Representative photomicrographs of collagen I and III immunohistochemistry
shows reduced collagen deposition in KKAy infarct area compared to WT. (a) and (b)
demonstrates collagen I and III staining in the WT infarct region, respectively, while (c) and
(d) demonstrates collagen I and III staining in the KKAy infarct region, respectively,
magnification is 40X, scale bar is 50 μm. Each insert shows a 1.25X view of the post-MI LV
infarcted wall.
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Figure 5.
The KKAy mice showed reduced blood vessel density in the infarct region at d7 post-MI. LV
mid cavity sections were stained with Griffonia (Bandeiraea) simplicifolia lectin-I (GSL-1)
to depict blood vessels. Representative images of WT (a and b) and KKAy (c and d) mice
stained with GSL-1 from remote and infarcted areas at d7 post-MI (magnification is 40x,
scale bar is 100 μm). (e) The percent density of GSL-1 stained areas, n= 4/group, *p<0.05
vs. WT at 7d post-MI, Values are mean ± SEM. (f) Plasma VEGF-A (ng/ml) levels
unchanged between WT and KKAy mice at d0 and at d7 post-MI.
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Table 1
Post-MI survival is decreased in KKAy mice.
Wild type (n=17, M/F=9/8) % KKAy (n=32, M/F=20/12) %
Day 0 control 7 -- 10 --
Post-MI 7 day survival 7 70 10 45*
Peri-operative mortality (died in the first 24 hours) 1 10 5 23
Post-operative mortality (died from days 1 to 7) 1 10 5 23
Non-MI survivor 1 10 2 9
MI- myocardial infarction; n- number of mice; M- male; F- female; MI- myocardial infarction.
Group comparisons were made by Fisher’s exact test;
*
p<0.05 vs. WT.
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Table 2
Echocardiography and necropsy analyses show an improved remodeling response in the KKAy mice post-MI.
WT and KKAy showed no differences at baseline.
Parameters/Genotype WT Day 0 control(n=7)
KKAy Day 0 control
(n=10)
WT Day 7 Post-MI (n=7) KKAy Day 7 Post-MI
(n=10)
Age (months) 6 ± 1 6 ± 1 6 ± 1 7 ± 1
Heart Rate, beats/min 445 ± 16 410 ± 7 460 ± 40 496 ± 40
End-diastolic dimension, mm 3.71 ± 0.10 3.78 ± 0.14 6.16 ± 0.42* 5.80 ± 0.34*¥
End-systolic dimension, mm 2.38 ± 0.10 2.30 ± 0.20 5.88 ± 0.44* 5.24 ± 0.37*¥
LV free wall thickness s, mm 1.21 ± 0.03 1.34 ± 0.08 0.47 ± 0.07* 0.52 ± 0.06*
Fractional shortening, % 36 ± 2 40 ± 3 5 ± 1* 10 ± 2*¥
End diastolic volume, μl 49 ± 6 54 ± 4 139 ± 20* 130 ± 19*
End systolic volume, μl 19 ± 4 22 ± 3 122 ± 20* 110 ± 11*
Ejection fraction, % 62 ± 4 59 ± 4 14 ± 3* 18 ± 3*
LV mass, mg 81 ± 5 81 ± 4 99 ± 4* 102 ± 7*
RV mass, mg 21 ± 1 23 ± 2 28 ± 1* 25 ± 2*
Lung wet weight, mg 122 ± 6 130 ± 4 233 ± 25* 217 ± 23*
LV mass/tibia, mg/mm 4.8 ± 0.3 4.8 ± 0.2 5.8 ± 0.2* 5.9 ± 0.4*
LV remodeling index, μl/mg -- -- 1.41 ± 0.20 1.23 ± 0.12
Infarct size, % -- -- 50 ± 4 49 ± 2
Values are mean and ± SEM, n- number of mice. Controls are mice evaluated at Day 0.
Abbreviations are LV- left ventricle, MI- myocardial infarction, RV- right ventricle, and WT- wild type. LV remodeling index is end-diastolic
volume/LV mass.
*
p<0.05 vs. respective Day 0 control,
¥
p<0.05 vs. WT Day 7 Post-MI.
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